HOME >> BIOLOGY >> NEWS
Leading scientists gather to discuss developments in infectious disease research

SAVE THE DATE

Leading Scientists Gather to Discuss Developments in Research, Prevention and Treatment of Emerging Global Viruses

WHO: The American Society Of Tropical Medicine And Hygiene (ASTMH)

WHAT: The Latest Findings Regarding the Prevention, Treatment and Containment of Emerging and Global Infectious Diseases

WHEN: November 12-16, 2006

WHERE: ASTMH 55th Annual Meeting at the Atlanta Marriott Marquis, Atlanta, Ga.

BACKGROUND: More than 2,000 leading researchers and scientists in the area of infectious and emerging disease are expected to attend the 55th Annual Meeting of the American Society of Tropical Medicine and Hygiene to discuss science and issues related to the prevention and treatment of global health threats. Topics and speakers scheduled for the Atlanta meeting this year include:

  • Infectious diseases affecting members of the active military

  • Diseases in the Tropics What travelers need to know -- updates on infectious diseases commonly encountered in the developing world, including malaria, leishmaniasis, Dengue fever and food and water-borne protozoan parasites

  • Disease threats posed by domestic and wild animals, including West Nile disease and Monkey Pox

  • Why we are seeing an increase in Bubonic Plague cases in the United States

  • Development of New Drugs for Tropical and Emerging Diseases -- exploring existing efforts to develop new medicines to treat tropical and emerging diseases that lack adequate therapies, particularly for malaria

  • Immigrant and refugee health, including immunizations and women's health issues

    Special Guest Speakers:

  • Julie L. Gerberding, M.D., M.P.H., Director of the Center for Diseases Control, Atlanta, Ga., who will address: Menaces, Mysteries and Marvels: Combating 21st Century Microbes

  • Roger Glass, M.D., Ph.D., direc
    '"/>


Contact: Jennifer Garber
jgarber@environics-usa.com
203-325-8772
American Society of Tropical Medicine and Hygiene
18-Oct-2006


Page: 1 2

Related biology news :

1. Leading the fight against food poisoning
2. Leading researchers honored for progress in cancer prevention, detection and treatment
3. Leading drug discovery and biotechnology scientists and experts discuss latest advancements
4. Leading cause of US food-borne illness makes its own pathway through cells
5. Leading scientists elected to EMBO ranks
6. Leading stem cell expert moves to UK
7. Leading breast cancer researcher awarded new lectureship
8. Leading experts confront global burden of chronic disease 8 Dec. at Abelson Science Seminar
9. Leading researchers from Israel and Southern California to present stem cell symposium
10. Leading experts present latest in cancer prevention research
11. Leading lampreys to slaughter: Pheromone for scourge of Great Lakes identified

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... (PRWEB) , ... August 25, ... ... clinical-stage biotechnology company developing novel pharmaceuticals targeting mitochondria, in partnership with Essex ... enrolment in its pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ophthalmic ...
(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., a ... U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New Drug ... of severe COVID-19. Approval of this IND allows Sentien to initiate a Phase ...
(Date:8/12/2020)... SOUTHFIELD, Mich. (PRWEB) , ... August 11, 2020 ... ... Janssen R&D subsidiary based in Princeton, NJ, have entered into license agreements with ... discovery and development. Both Roche and J&J have annual Research and Development ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... 11, 2020 , ... The FSHD Society announced today that ... Clinical Trial Research Network (FSHD CTRN), with consideration of follow-on funding of ... academic research centers in the United States and Europe with expertise in FSHD ...
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a highly regarded CDMO ... the purchase of greenfield for a new, expanded manufacturing facility. The site is ... in the initial acquisition, with an option to purchase an additional 21 acres ...
(Date:7/31/2020)... ... ... R3 Stem Cell International is now offering patients the opportunity to receive ... patients may choose which extremities they would like treated. , Several studies have shown ... At R3 International, umbilical cord tissue is obtained from a lab with a long ...
(Date:7/31/2020)... , ... July 29, 2020 , ... ... can combine up to three different materials for use with CRM, neurostimulation, vascular, ... to three materials to meet specific design requirements, performance, and cost criteria; especially ...
Breaking Biology Technology:
Cached News: